• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD
Intellinews - Polish Pharmaceutical Sector Report - 2012 Product Image

Intellinews - Polish Pharmaceutical Sector Report - 2012

  • ID: 2306097
  • November 2012
  • Region: Poland
  • 16 Pages
  • Emerging Markets Direct

FEATURED COMPANIES

  • ACP Pharma
  • Bioton
  • Farmacol
  • Medana Pharma
  • Oleofarm
  • Polpharma
  • MORE

The IntelliNews Polish Pharmaceutical Sector Report offers an extensive summary of the Polish pharmaceuticals production and distribution markets. It includes a complete coverage of market volume, sales dynamics, corporate news, accompanied by thorough statistics and comments. This sector report is ideal to keep you abreast on recent company and industry news. Written by local professionals, it is a unique market and business intelligence analysis, tailored to save time by providing in-depth information, while helping you to make confident and informed business decisions.

Executive Summary

The Polish pharmaceutical market value (in gross retail prices) rose by 3.7% y/y to around PLN 22.3bn (EUR 5.4bn) in 2011, at a similar growth pace as in 2010, according to market estimates. Nonetheless, medicine sales turned on the negative side this year, affected by the new controversial reimbursement act enforced in January. Pharmaceuticals sales value dropped by approximately 4% y/y in Jan-Sep 2012, according to market data. The decline was noticeable not only on the retail level, but also in medicine output. According to our calculations based on official statistics, the pharmaceuticals READ MORE >

Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • ACP Pharma
  • Bioton
  • Farmacol
  • Medana Pharma
  • Oleofarm
  • Polpharma
  • MORE

Executive summary

Market overview
- Pharma market rises 3.7% y/y in 2011, turns on negative side in Jan-Sep 2012
- New drug reimbursement act troubles pharmaceutical market
- OTC sector expected to record positive y/y performance in 2012
- Reimbursed drug segment to contract by PLN 2bn in 2012
- Wholesale market expected to continue consolidating

Producers - Operations
- Medana Pharma moves on with investments in upgrading production lines
- Sandoz reportedly mulls PLN 125mn investment in new plant in Strykow
- Sanofi inaugurates distribution centre near Warsaw
- Slovenian Krka debuts on WSE in April
- Adamed concentrates on boosting exports, OTC segment
- Biogened increases exposure to dietary supplements, dermocosmetics in Q2
- Mabion expands to Middle East markets
- Swiss Octapharma withdraws from EUR 100mn planned investment in plasma processing plant
- Bioton to introduce new lines this year, continues expansion abroad
- Synektik starts radiopharmaceuticals production in new Kielce facility
- Turkish Monrol to build PLN 20mn radiopharmaceuticals plant in Warsaw
- Warsaw University opens radiopharmaceuticals production unit

Producers – M&A
- Polpharma finalises acquisition of drug maker Polfa Warszawa
- Polfarmex chases acquisition of domestic peers
- Aflofarm puts for sale 23 brands, as part of optimising portfolio strategy
- Oleofarm in talks with financial, strategic investors, expects to close deal in Q1/2013
- Bioton raises stake in veterinary medicine producer Biolek
- Valeant’s PharmaSwiss purchases part of VitaDirect’s brands
- Italian pharma company Recordati takes over Polish peer Farma-Projekt.

Distributors - Operations
- Largest distributor Neuca projects PLN 60mn net profit in 2012
- Pelion cuts jobs, closes unprofitable pharmacies
- Farmacol’s profitability improves y/y, sales shrink in H1/2012
- Ciech Polfa’s sales plunge 26.5% y/y in Jan-Aug 2012

Distributors – M&A
- Treasury ministry resumes privatisation of CF Cefarm
- ACP Pharma increases stake in Cefarm Rzeszow to 93%
- Diabetic devices distributor BM Medical completes acquisition of Ciech Polfa
- Pharmacy chain Farmacja 24 takes over peer Apteka pod Roza
- Scandinavian Tamro group fails finding buyer for Phoenix Pharma Polska

Table 1 Pharmaceutical sales in 2011 (PLN bn, y/y)
Table 2 Medana Pharma S.A. - Selected financials in 2007 - 2010 (individual, PLN mn)
Table 3 Sanofi Aventis Sp. z o.o. - Selected financials in 2008 - 2011 (individual, PLN mn)
Table 4 Biogened S.A. - Selected financials in 2011 - 2012 (PLN thou)
Table 5 Bioton S.A. - Selected financials in 2011 - 2012 (consolidated, PLN mn)
Table 6 Synektika S.A. - Selected financials in 2011 - 2012 (consolidated, PLN mn)
Table 7 Neuca S.A. - Selected financials in 2010 - 2012 (half-year, consolidated, PLN mn)
Table 8 Cefarm Rzeszow S.A. - Selected financials in 2009 - 2011 (annual, PLN mn)

Figure 1 Pharmaceutical market value in retail prices in 2011 - 2012 (monthly, PLN bn)
Figure 2 Pharmaceutical products - Sold production volume index in 2008 - 2012 (monthly, 2005=100)
Figure 3 Pharmaceuticals production index in 2009 - 2012 (quarterly, y/y)
Figure 4 OTC market value in 2008 - 2014f (PLN mn, y/y)
Figure 5 Structure of pharma sales in 2011 - 2012f (% in total)
Figure 6 Neuca S.A. - Net sales revenues in 2010 - 2012 (consolidated, quarterly, PLN mn)
Figure 7 Neuca S.A. - Net profit in 2010 - 2012 (consolidated, quarterly, PLN mn)
Figure 8 Pelion S.A. - Net sales revenues in 2010 - 2012 (consolidated, quarterly, PLN mn)
Figure 9 Pelion S.A. - Net profit in 2010 - 2012 (consolidated, quarterly, PLN mn)
Figure 10 Farmacol S.A. - Net sales revenues in 2010 - 2012 (consolidated, quarterly, PLN mn)
Figure 11 Farmacol S.A. - Net profit in 2010 - 2012 (consolidated, quarterly, PLN mn)

Note: Product cover images may vary from those shown

- Medana Pharma
- Sandoz
- Sanofi
- Krka
- Adamed
- Biogened
- Mabion
- Octapharma
- Bioton
- Synektik
- Monrol
- Polpharma
- Polfarmex
- Aflofarm
- Oleofarm
- Valent
- Recordati
- Farma-Projekt
- Neuca
- Pelion
- Farmacol
- Ciech Polfa
- ACP Pharma
- BM Medical
- Farmacja
- Tamro
- Phoenix Pharma

Note: Product cover images may vary from those shown
Note: Product cover images may vary from those shown

RELATED PRODUCTS

Our Clients

Our clients' logos